Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 28 studies | 28% ± 12% | |
plasmacytoid dendritic cell | 12 studies | 32% ± 10% | |
conventional dendritic cell | 12 studies | 29% ± 14% | |
capillary endothelial cell | 12 studies | 22% ± 5% | |
endothelial cell of artery | 11 studies | 27% ± 4% | |
B cell | 10 studies | 24% ± 9% | |
vein endothelial cell | 10 studies | 24% ± 7% | |
dendritic cell | 8 studies | 35% ± 23% | |
naive B cell | 6 studies | 29% ± 7% | |
macrophage | 5 studies | 33% ± 11% | |
non-classical monocyte | 5 studies | 31% ± 6% | |
memory B cell | 5 studies | 25% ± 5% | |
endothelial cell of vascular tree | 5 studies | 36% ± 19% | |
endothelial cell of lymphatic vessel | 4 studies | 22% ± 5% | |
brush cell | 4 studies | 44% ± 18% | |
mast cell | 3 studies | 27% ± 2% | |
monocyte-derived dendritic cell | 3 studies | 42% ± 17% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 32% ± 3% | |
classical monocyte | 3 studies | 18% ± 0% | |
glomerular endothelial cell | 3 studies | 38% ± 8% | |
myeloid cell | 3 studies | 23% ± 7% |
Insufficient scRNA-seq data for expression of TAMALIN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2276.15 | 652 / 653 | 98% | 16.43 | 591 / 605 |
prostate | 99% | 2215.56 | 243 / 245 | 97% | 13.47 | 486 / 502 |
ovary | 100% | 2027.73 | 180 / 180 | 92% | 10.91 | 397 / 430 |
lung | 100% | 6834.31 | 578 / 578 | 92% | 10.50 | 1059 / 1155 |
breast | 100% | 3571.47 | 459 / 459 | 86% | 8.13 | 966 / 1118 |
kidney | 100% | 1795.34 | 89 / 89 | 86% | 17.35 | 777 / 901 |
bladder | 100% | 1858.10 | 21 / 21 | 86% | 8.06 | 434 / 504 |
esophagus | 91% | 1483.18 | 1322 / 1445 | 92% | 9.16 | 168 / 183 |
uterus | 100% | 2802.72 | 170 / 170 | 82% | 10.55 | 377 / 459 |
brain | 80% | 1489.54 | 2119 / 2642 | 100% | 21.66 | 704 / 705 |
intestine | 97% | 1277.47 | 938 / 966 | 82% | 6.26 | 432 / 527 |
skin | 78% | 1063.24 | 1404 / 1809 | 99% | 30.82 | 469 / 472 |
stomach | 89% | 943.89 | 319 / 359 | 85% | 7.95 | 242 / 286 |
adrenal gland | 82% | 850.61 | 212 / 258 | 83% | 15.59 | 190 / 230 |
pancreas | 59% | 409.30 | 193 / 328 | 98% | 19.31 | 175 / 178 |
adipose | 100% | 4161.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 21.28 | 80 / 80 |
spleen | 100% | 2973.18 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.30 | 1 / 1 |
heart | 99% | 1970.67 | 856 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 7.78 | 28 / 29 |
liver | 22% | 153.69 | 50 / 226 | 74% | 5.82 | 302 / 406 |
blood vessel | 91% | 1309.58 | 1212 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 8.74 | 39 / 45 |
muscle | 86% | 801.82 | 689 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 29% | 379.38 | 274 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0099152 | Biological process | regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0014069 | Cellular component | postsynaptic density |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031267 | Molecular function | small GTPase binding |
Gene name | TAMALIN |
Protein name | Protein TAMALIN (General receptor for phosphoinositides 1-associated scaffold protein) (GRP1-associated scaffold protein) Trafficking regulator and scaffold protein tamalin |
Synonyms | GRASP |
Description | FUNCTION: Plays a role in intracellular trafficking and contributes to the macromolecular organization of group 1 metabotropic glutamate receptors (mGluRs) at synapses. . |
Accessions | Q7Z6J2 F8VRX5 ENST00000552049.5 [Q7Z6J2-2] ENST00000546756.1 ENST00000293662.9 [Q7Z6J2-1] |